
Casirivimab/imdevimab enhance outcomes in early COVID-19
The extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes the coronavirus illness 2019 (COVID-19). Since its emergence on the finish of 2019, SARS-CoV-2 has contaminated over 550 million and induced